The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Lakshmanan Krishnamurti named chief of pediatric hematology, oncology, and bone marrow transplant at Yale

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Lakshmanan Krishnamurti was named chief of pediatric hematology, oncology, and bone marrow transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program. 

Krishnamurti is a pediatric hematologist oncologist and an expert in bone marrow transplant and the treatment of hemoglobinopathies.

Krishnamurti joins Yale from Emory University School of Medicine, where he is director of the Bone Marrow Transplantation Program and professor of pediatrics and holds the Joseph Kuechenmeister Aflac Field Force Chair at Children’s Healthcare of Atlanta. 

Krishnamurti begins his role Oct. 1.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
By Rodney Haring
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account